Pathology Laboratories Market was valued at USD 355.56 billion in 2023 and is expected to reach USD 720.60 billion by 2032, growing at a CAGR of 8.13% from 2024-2032.
Pathology Laboratories Market report provides valuable insights into utilization rates, examining the diagnostic tests conducted in 2023 and their availability across healthcare facilities. It offers a regional segmentation of test type trends, emphasizing differences in demand for general, imaging, and esoteric tests. The report root into growth in laboratory volumes between 2020 and 2032, highlighting trends in hospital-based, freestanding, and diagnostic chain laboratories. The report also provides an in-depth examination of healthcare expenditures on diagnostic testing, dividing spending into government, commercial, private, and out-of-pocket sources, providing a broad perspective on financial dynamics within the industry.
Drivers
Rising global disease burden propelling the pathology laboratories market growth.
The rising incidence of chronic conditions like cancer, infectious diseases, and metabolic disorders is a major growth driver for the pathology laboratories market. With these health conditions increasing in prevalence, the need for efficient and accurate diagnostic services increases, and this, in turn, increases the utilization of pathology laboratories. The growth captures the growing demand for diagnostic services to control the upsurge in the incidence of chronic diseases. Recent additions, including the inauguration of new laboratories by Redcliffe Labs in New Delhi in August 2024, further illustrate the sector's reaction to such growing demand. Moreover, technological advancements in molecular diagnostics and biomarker-based tests are enhancing the detection of diseases at an early stage, boosting patient outcomes, and propelling further growth in pathology services.
Technological advancements in diagnostic services accelerated the pathology laboratory market.
Progress in diagnostic technologies, most notably the convergence of artificial intelligence (AI) and digital pathology, is driving the pathology laboratories market. These technologies improve the accuracy, efficiency, and pace of disease diagnosis. For instance, in May 2024, Quest Diagnostics joined forces with PathAI to expand the adoption of AI-assisted digital pathology solutions to enhance diagnostic accuracy and operational effectiveness. In the same vein, Sonic Healthcare's PathologyWatch launched an integrated digital pathology platform in March 2024, transforming dermatopathology reporting with AI-powered tools. These advances not only enhance patient outcomes but also overcome issues like the worldwide shortage of pathologists by boosting productivity and diagnostic capacity.
Restraint
Regulatory Challenges and Compliance Burdens restraining the market growth.
The pathology laboratories market is confronted with major challenges in the form of strict regulatory norms and changing compliance standards. Laboratories have to comply with numerous national and international regulations, including CLIA (Clinical Laboratory Improvement Amendments) in the United States and ISO 15189 accreditation for medical laboratories across the globe. Compliance with these regulations requires huge investments in quality assurance, infrastructure, and training of personnel, which raises the cost of operations. The U.S. Food and Drug Administration (FDA) has been imposing more stringent regulations on laboratory-developed tests (LDTs) recently, creating industry concerns. In August 2024, a large American medical association filed a lawsuit against the FDA to prevent new regulations for LDTs, citing mounting tensions between regulators and laboratories. Such compliance obstacles can hamper innovation and stifle market expansion, especially for small diagnostic laboratories.
Opportunities
The growing adoption of personalized and precision medicine presents a significant opportunity for the pathology laboratories market.
The increasing uptake of precision and personalized medicine creates a major opportunity for the pathology laboratories industry. Improvements in genomic and molecular diagnostics are making it possible to treat, more specifically, pushing demand for specialized pathology services. As healthcare moves more towards individualized therapy regimens, pathology laboratories are at the forefront of genetic marker analysis, disease progression prediction, and therapy choice guidance. For example, the greater adoption of next-generation sequencing (NGS) in cancer oncology has augmented early cancer diagnosis and personalized therapy. Furthermore, partnerships between pharma and diagnostics companies are fueling the evolution of companion diagnostics, further fueling market opportunities. As there is ongoing advancement in biomarker discovery and AI-driven pathology, laboratories stand ready to leverage this emerging healthcare trend.
Challenges
A critical challenge facing the pathology laboratories market is the global shortage of skilled pathologists and laboratory technicians.
A key challenge to the pathology laboratories market is the worldwide shortage of skilled pathologists and laboratory technicians. An increasing need for diagnostic testing, combined with an aging workforce, has created staffing shortages that affect laboratory efficiency and turnaround time. It has been reported that in certain areas, a single pathologist may review thousands of cases in a year, which could create possible delays in diagnosis and added pressure on workload. This problem is especially common in rural and underserved communities where specialized diagnostic services are not readily available. Although digital pathology and AI-based diagnostics are alleviating this problem, the demand for highly skilled professionals is still critical. To solve this shortage, more investment needs to be made in education, training initiatives, and workforce retention.
By Type
The hospital-based segment dominated the pathology laboratories market in 2023 with a 53.65% market share because of the extensive diagnostic services provided in hospitals, providing fast and precise disease diagnosis for inpatients and outpatients. Hospitals possess well-equipped pathology laboratories combined with sophisticated imaging and molecular diagnostic technologies, which facilitate smooth workflow between clinicians and laboratory staff. Further, hospital laboratories perform large volumes of significant tests, such as emergency and specialty diagnostic services, which are required in disease management and treatment planning. Skilled pathologists on board, reduced turnaround times, and the capability to carry out intricate testing procedures also enhanced the segment's leadership. Further, hospitals are supported with government funding and insurance reimbursement, thereby making pathology services highly accessible across the country and upholding their market leadership.
The diagnostic chains segment will experience the fastest growth in forecast years with growing demand for high-quality and cost-efficient specialist diagnostic services away from hospital locations. Diagnostic chains like Quest Diagnostics and Sonic Healthcare are growing their networks with several collection centers and regional labs, thus offering pathology services to patients. The increasing need for home-based sample collection and integration of digital health is also propelling the growth of the segment. Moreover, diagnostic chains utilize sophisticated automation, AI-based diagnostics, and centralized processing centers, which provide high efficiency and standardized testing across geographies. The increasing incidence of chronic diseases, growing awareness of preventive healthcare, and strategic collaborations with healthcare providers are likely to drive the aggressive growth of diagnostic chains in the future.
By Testing Services
The General Physiological & Clinical Tests segment dominated the pathology laboratories market with a 38.15% market share in 2023 because of the increased demand for routine diagnostic tests employed for disease screening, monitoring, and preventive care. Tests such as blood tests, urine tests, liver function tests, and complete blood count (CBC) are commonly prescribed by doctors to examine overall health and identify prevalent diseases like diabetes, anemia, and infections. The mounting incidence of chronic diseases and the increasing focus on early disease diagnosis have further increased the demand for these tests. Moreover, these diagnostic services are easily accessible through hospitals, diagnostic chains, and independent labs, covering a huge patient base. Government schemes focusing on routine health check-ups and preventive care have also fueled the dominance of the segment.
The Esoteric Tests segment is anticipated to witness the fastest growth in the forecast period with a 9.73% CAGR on account of the increasing uptake of specialized and sophisticated diagnostic methods for rare and complex diseases. Such tests, such as genetic testing, molecular diagnostics, and biomarker analysis, are becoming increasingly popular as precision medicine and targeted therapies gain traction. The growing prevalence of cancer, autoimmune diseases, and infectious illnesses has contributed to the demand for high-complexity testing capable of yielding greater insight into disease processes. Moreover, developments in next-generation sequencing (NGS) and liquid biopsy technologies are transforming personalized diagnostics, contributing significantly to market expansion. The growth of reference laboratories with expertise in esoteric testing and partnerships among biotech companies and pathology labs are likely to drive the use of these high-value diagnostic services in the future.
By End-Use
The Physician Referrals segment dominated the pathology laboratories market with a 53.41% market share in 2023 because physicians ordered a very large number of diagnostic tests to diagnose diseases, monitor treatment, and provide preventive care. Doctors are important guides for patients on the way toward required laboratory exams, allowing appropriate and timely diagnostics of many sicknesses as the majority of pathology tests are ordered based on clinical assessment, hospitals and private clinics partner with pathology labs to ensure smooth testing services. Moreover, the growing incidence of chronic conditions like diabetes, cardiovascular diseases, and cancer has also fueled the demand for physician-referred diagnostic tests. Insurance claims and medical policies covering physician-ordered tests have also bolstered this segment's leadership by enhancing patient access to critical diagnostic services.
The Corporate segment is expected to witness the fastest growth in the forecast period with a 9.15% CAGR as a result of increasing focus on employee health and wellness programs. Companies are investing in preventive healthcare programs by collaborating with diagnostic laboratories to provide routine health checks, such as blood tests, cardiovascular evaluation, and cancer screening. Growing corporate knowledge of workplace health and the economic payback of early disease diagnosis has motivated companies to add pathology testing as part of employee benefit programs. Tax incentives and government legislation encouraging occupational health are also propelling companies to adopt diagnostic services. The increasing trend of corporate alliances with diagnostic chains and the incorporation of digital health solutions for remote screening is likely to further drive the growth of this segment during the forecast years.
North America dominated the pathology laboratories market with a 38.25% market share in 2023 by its well-developed healthcare infrastructure, high rate of uptake of sophisticated diagnostic technologies, and high density of leading market players. The region is characterized by a high incidence of chronic diseases like cancer, cardiovascular diseases, and infectious diseases, and this boosts the requirement for diagnostic testing. Moreover, government programs and healthcare policies, including Medicare and Medicaid reimbursement schemes, facilitate mass access to pathology services. The presence of prominent diagnostic firms, including Quest Diagnostics, Laboratory Corporation of America (LabCorp), and Thermo Fisher Scientific, also consolidates North America's market leadership. Furthermore, continuous developments in digital pathology, AI-driven diagnostics, and automation have enhanced efficiency and precision in laboratory work, solidifying the region's dominance.
Asia Pacific is the fastest-growing region in the pathology laboratories market throughout the forecast period, with a 9.28% CAGR, supported by rising healthcare expenditure, expanding disease burden, and enhanced diagnostic facilities. Urbanization, aging demographics, and growing awareness of detecting diseases at early stages have triggered demand for pathology services in markets such as China, India, and Japan. Government programs that aim to expand healthcare access, including India's Ayushman Bharat program and China's health reforms, are also propelling market growth. Moreover, growth in private diagnostic labs and high uptake of AI-based digital pathology solutions are redefining the diagnostic landscape in the region. The increasing numbers of international lab service providers and partnerships with domestic healthcare organizations are also driving fast growth in pathology services in Asia Pacific.
Quest Diagnostics (Comprehensive Metabolic Panel, QuestDirect COVID-19 Active Infection Test)
Laboratory Corporation of America (LabCorp) (Pixel by LabCorp At-Home Kits, Oncology Diagnostic Services)
Sonic Healthcare (Clinical Laboratory Testing Services, Anatomical Pathology Services)
Healius Limited (Pathology Testing Services, Genomic Diagnostics)
Australian Clinical Labs (Routine Blood Tests, Histopathology Services)
Abbott Laboratories (ARCHITECT c4000 Clinical Chemistry Analyzer, Alinity m Molecular Diagnostics System)
Siemens Healthineers (ADVIA Centaur XP Immunoassay System, Atellica Solution Immunoassay & Clinical Chemistry Analyzers)
Roche Diagnostics (cobas 8000 Modular Analyzer Series, Ventana BenchMark ULTRA IHC/ISH System)
Thermo Fisher Scientific (Phadia 250 Allergy Testing System, Ion Torrent Genexus System)
Danaher Corporation (Leica Biosystems Pathology Imaging Solutions, Beckman Coulter DxH 900 Hematology Analyzer)
PerkinElmer Inc. (Vectra Polaris Automated Quantitative Pathology Imaging System, EnVision Multimode Plate Reader)
Sysmex Corporation (XN-Series Hematology Analyzers, DI-60 Digital Image Analyzer)
Bio-Rad Laboratories, Inc. (QX200 Droplet Digital PCR System, BioPlex 2200 Multiplex Immunoassay System)
Beckman Coulter (AU5800 Series Clinical Chemistry Analyzers, DxI 800 Immunoassay System)
Applied Spectral Imaging (HiPath Pro, PathFusion)
Clarapath (Automated Microtomy Solutions, Digital Pathology Platforms)
HistoWiz (Automated Histology Services, Digital Slide Scanning)
Babson Diagnostics (Small-Volume Blood Collection Device, Sample Handling Machine)
Truvian Health (Easy Check COVID-19 Test Kit, Point-of-Care Blood Testing System)
INHECO Industrial Heating & Cooling GmbH (Thermoshake AC, Thermoshake Classic)
Suppliers (These suppliers provide a range of products and services essential for the efficient operation of pathology laboratories, contributing to advancements in diagnostic capabilities and patient care.)
Medline Industries
USA Lab Equipment
MFI Medical
Naugra Export
Hospital Laboratory India
S.V. Scientific Centre
Leica Biosystems
Ventana Medical Systems
Midland Scientific
Antylia Scientific
In May 2024, Quest Diagnostics, a healthcare testing company providing diagnostic information services, introduced a strategic alliance with PathAI, a renowned world leader in pathology technology backed by artificial intelligence. The new collaboration is established with the target to speed up digital and AI technology adoption within pathology, providing increased quality, efficiency, and faster diagnosis of cancer and other illnesses.
March 2024 – Sonic Healthcare's PathologyWatch has launched an advanced, fully integrated digital pathology platform dedicated to skin pathology. Utilizing its proprietary 'dot.' (dermatopathology optimization tool), the platform combines a laboratory information system, digital pathology viewer, image storage, and AI-driven algorithms. This new system improves dermatopathology reporting, offering an optimized experience for both pathologists and referring physicians.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 355.56 Billion |
| Market Size by 2032 | US$ 720.60 Billion |
| CAGR | CAGR of 8.13% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Hospital-based, Standalone Labs, Diagnostic Chains) • By Testing Services (General Physiological & Clinical Tests, Imaging & Radiology Tests, Esoteric Tests, COVID-19 Tests) • By End-Use (Physician Referrals, Walk-ins, Corporate) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Quest Diagnostics, Laboratory Corporation of America (LabCorp), Sonic Healthcare, Healius Limited, Australian Clinical Labs, Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Thermo Fisher Scientific, Danaher Corporation, PerkinElmer Inc., Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter, Applied Spectral Imaging, Clarapath, HistoWiz, Babson Diagnostics, Truvian Health, INHECO Industrial Heating & Cooling GmbH, and other players. |
Ans: The Pathology Laboratories Market is expected to grow at a CAGR of 8.13% from 2024 to 2032.
Ans: The Pathology Laboratories Market was USD 355.56 billion in 2023 and is expected to Reach USD 720.60 billion by 2032.
Ans: Technological advancements in diagnostic services accelerated the pathology laboratory market.
Ans: The “General Physiological & Clinical Tests” segment dominated the Pathology Laboratories Market.
Ans: North America dominated the Pathology Laboratories Market in 2023.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Test Volume and Utilization Rate (2023)
5.2 Test Type Trends (2023), by Region
5.3 Laboratory Volume and Growth, by Region (2020-2032)
5.4 Healthcare Spending on Diagnostic Testing, by Region (Government, Commercial, Private, Out-of-Pocket) (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Pathology Laboratories Market Segmentation, by Type
7.1 Chapter Overview
7.2 Hospital-based
7.2.1 Hospital-based Market Trends Analysis (2020-2032)
7.2.2 Hospital-based Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Standalone Labs
7.3.1 Standalone Labs Market Trends Analysis (2020-2032)
7.3.2 Standalone Labs Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Diagnostic Chains
7.4.1 Diagnostic Chains Market Trends Analysis (2020-2032)
7.4.2 Diagnostic Chains Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Pathology Laboratories Market Segmentation, by Testing Services
8.1 Chapter Overview
8.2 General Physiological & Clinical Tests 1
8.2.1 General Physiological & Clinical Tests 1 Market Trends Analysis (2020-2032)
8.2.2 General Physiological & Clinical Tests 1 Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Imaging & Radiology Tests
8.3.1 Imaging & Radiology Tests Market Trends Analysis (2020-2032)
8.3.2 Imaging & Radiology Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Esoteric Tests
8.4.1 Esoteric Tests Market Trends Analysis (2020-2032)
8.4.2 Esoteric Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 COVID-19 Tests
8.5.1 COVID-19 Tests Market Trends Analysis (2020-2032)
8.5.2 COVID-19 Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Pathology Laboratories Market Segmentation, by End User
9.1 Chapter Overview
9.2 Physician Referrals
9.2.1 Physician Referrals Market Trends Analysis (2020-2032)
9.2.2 Physician Referrals Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Walk-ins
9.3.1 Walk-ins Market Trends Analysis (2020-2032)
9.3.2 Walk-ins Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Corporate
9.4.1 Corporate Market Trends Analysis (2020-2032)
9.4.2 Corporate Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Pathology Laboratories Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.2.5 North America Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.2.6.3 USA Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.2.7.3 Canada Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.2.8.3 Mexico Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Pathology Laboratories Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.1.6.3 Poland Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.1.7.3 Romania Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Pathology Laboratories Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.2.5 Western Europe Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.2.6.3 Germany Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.2.7.3 France Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.2.8.3 UK Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.2.9.3 Italy Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.2.10.3 Spain Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.2.13.3 Austria Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Pathology Laboratories Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.4.5 Asia Pacific Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.4.6.3 China Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.4.7.3 India Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.4.8.3 Japan Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.4.9.3 South Korea Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.4.10.3 Vietnam Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.4.11.3 Singapore Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.4.12.3 Australia Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Pathology Laboratories Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.5.1.5 Middle East Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.5.1.6.3 UAE Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Pathology Laboratories Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.5.2.5 Africa Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Pathology Laboratories Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.6.5 Latin America Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.6.6.3 Brazil Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.6.7.3 Argentina Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.6.8.3 Colombia Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Pathology Laboratories Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Pathology Laboratories Market Estimates and Forecasts, by Testing Services (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Pathology Laboratories Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11. Company Profiles
11.1 Quest Diagnostics
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Laboratory Corporation of America
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Sonic Healthcare
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Healius Limited
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Australian Clinical Labs
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Abbott Laboratories
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Siemens Healthineers
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Roche Diagnostics
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Thermo Fisher Scientific
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Danaher Corporation
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Pathology Laboratories Market Key Segments:
By Type
Hospital-based
Standalone Labs
Diagnostic Chains
By Testing Services
General Physiological & Clinical Tests
Imaging & Radiology Tests
Esoteric Tests
COVID-19 Tests
By End-Use
Physician Referrals
Walk-ins
Corporate
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Immunology Market Size was valued at USD 97.58 Billion in 2023, and is expected to reach USD 254.23 Billion by 2032, and grow at a CAGR of 11.8%.
The Lab Automation Market size was estimated at USD 7.31 billion in 2023 and is expected to reach USD 13.05 billion by 2032, with a growing CAGR of 6.65% during the forecast period of 2024-2032.
The Particle Counter Market Size was valued at USD 561.51 million in 2023, and is expected to reach USD 1212.42 million by 2031 and grow at a CAGR of 10.1% over the forecast period 2024-2031.
The Botulinum Toxin Market size was valued at USD 9.6 billion in 2023 and will reach USD 21.6 billion by 2032 growing at a CAGR of 9.4% by 2024-2032.
The Analytical Instrumentation Market Size was valued at USD 53 Billion in 2023 and is expected to reach USD 84.1 billion by 2032, growing at a CAGR of 5.3% by 2024-2032.
The Telehealth and Telemedicine Market Size was valued at USD 101.32 Billion in 2023, and is expected to reach USD 659.65 Billion by 2032, and grow at a CAGR of 24.52%.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
